Healthcare | April 07, 2026
World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Move aligns global biologics identity under the Biocon Biologics brand
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Subscribe To Our Newsletter & Stay Updated
